A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 184,700 shares of SENS stock, worth $86,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares
184,700
Previous 397,700 53.56%
Holding current value
$86,809
Previous $226,000 57.08%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.5 - $0.73 $45,296 - $66,132
90,593 Added 11.69%
865,643 $458,000
Q4 2023

Feb 14, 2024

BUY
$0.48 - $0.7 $371,302 - $541,482
773,547 Added 51466.87%
775,050 $441,000
Q3 2023

Nov 14, 2023

BUY
$0.5 - $1.05 $723 - $1,519
1,447 Added 2583.93%
1,503 $0
Q2 2023

Aug 14, 2023

BUY
$0.55 - $0.89 $30 - $49
56 New
56 $0
Q4 2022

Feb 14, 2023

BUY
$0.96 - $1.34 $227,831 - $318,014
237,324 Added 191.78%
361,070 $371,000
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $126,220 - $275,953
123,746 New
123,746 $164,000
Q1 2022

May 16, 2022

SELL
$1.54 - $3.71 $1.65 Million - $3.98 Million
-1,072,026 Reduced 34.63%
2,023,550 $3.99 Million
Q4 2021

Feb 14, 2022

BUY
$2.58 - $3.91 $7.71 Million - $11.7 Million
2,986,650 Added 2741.91%
3,095,576 $8.27 Million
Q3 2021

Nov 15, 2021

SELL
$2.77 - $4.05 $257,704 - $376,787
-93,034 Reduced 46.07%
108,926 $369,000
Q2 2021

Aug 16, 2021

SELL
$1.71 - $4.14 $2.03 Million - $4.91 Million
-1,184,874 Reduced 85.44%
201,960 $775,000
Q1 2021

May 17, 2021

BUY
$0.85 - $5.27 $1.05 Million - $6.51 Million
1,234,670 Added 811.41%
1,386,834 $3.66 Million
Q4 2020

Feb 16, 2021

BUY
$0.36 - $0.95 $6,689 - $17,652
18,582 Added 13.91%
152,164 $133,000
Q1 2020

May 15, 2020

BUY
$0.56 - $1.62 $60,565 - $175,207
108,153 Added 425.31%
133,582 $85,000
Q4 2019

Feb 14, 2020

SELL
$0.83 - $1.3 $12,376 - $19,384
-14,911 Reduced 36.96%
25,429 $23,000
Q3 2019

Nov 14, 2019

SELL
$0.97 - $1.94 $345,335 - $690,671
-356,016 Reduced 89.82%
40,340 $39,000
Q1 2019

May 15, 2019

BUY
$2.3 - $3.27 $837,494 - $1.19 Million
364,128 Added 1129.85%
396,356 $0
Q4 2018

Feb 14, 2019

SELL
$2.49 - $4.54 $36,443 - $66,447
-14,636 Reduced 31.23%
32,228 $83,000
Q3 2018

Nov 13, 2018

BUY
$3.4 - $4.84 $159,337 - $226,821
46,864 New
46,864 $0
Q4 2017

Feb 09, 2018

SELL
$2.43 - $3.54 $147,894 - $215,451
-60,862 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$2.22 - $3.2 $135,113 - $194,758
60,862
60,862 $194,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $219M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.